Skip to main content
. 2022 Aug 27;318:40–47. doi: 10.1016/j.jad.2022.08.080

Table 1.

Descriptive statistics of participants' baseline information.

Variables Total participants (n = 1571)
Sociodemographic characteristics
 Gender, n (%)
 Male 521 (33.2 %)
 Female 1050 (66.8 %)
 Age, years (Mean ± SD) 34.74 ± 7.77
 Ethnic group, n (%)
 Han 1543 (98.2 %)
 Minorities 28 (1.8 %)
 Religious belief, n (%)
 Yes 90 (5.7 %)
 No 1481 (94.3 %)
 Marital status, n (%)
 Single 222 (14.1 %)
 In love 106 (6.8 %)
 Married without children 152 (9.7 %)
 Married with children 1091 (69.4 %)
 Educational background, n (%)
 College 168 (10.7 %)
 Bachelor 1088 (69.3 %)
 Graduate 227 (14.4 %)
 Doctor 74 (4.7 %)
 Post-doctor 14 (0.9 %)
 Province, n (%)
 Beijing 41 (2.6 %)
 Out of Beijing 1530 (97.4 %)
 Department, n (%)
 Internal medicine 135 (8.6 %)
 Surgery 240 (15.3 %)
 Others 1196 (76.1 %)
 Academic rank, n (%)
 Clinical Practice 81 (5.2 %)
 Primary title 302 (19.2 %)
 Middle title 935 (59.5 %)
 High title 253 (16.1 %)
 Monthly income (CNY), n (%)
 <5000 651 (41.4 %)
 5000–10,000 719 (45.8 %)
 10,000–15,000 160 (10.2 %)
 >15,000 41 (2.6 %)
 Daily working time, Hours (Mean ± SD) 9.20 ± 1.86
 Number of Chronic diseases, n (%)
 0 1389 (88.4 %)
 1 151 (9.6 %)
 2 25 (1.6 %)
 ≥3 6 (0.4 %)
Uptake data of COVID-19 vaccine
 Supporting anti-epidemic in severe areas, n (%)
 Yes 74 (4.7 %)
 No 1497 (94.1 %)
 COVID-19 vaccination, n (%)
 Yes 1093 (69.6 %)
 No 478 (30.4 %)
 Number of vaccine-related adverse events, n (%)
 0 1187 (75.5 %)
 1–2 309 (19.7 %)
 ≥3 75 (4.8 %)
Psychological symptoms
 Depression, n (%)
 Normal 1181 (75.2 %)
 Mild 179 (11.4 %)
 Moderate 173 (11.0 %)
 Severe 28 (1.8 %)
 Extremely severe 10 (0.6 %)
 Anxiety, n (%)
 Normal 1068 (68.0 %)
 Mild 144 (9.2 %)
 Moderate 263 (16.7 %)
 Severe 57 (3.6 %)
 Extremely severe 39 (2.5 %)
 Stress, n (%)
 Normal 1047 (66.6 %)
 Mild 385 (24.5 %)
 Moderate 117 (7.5 %)
 Severe 16 (1.0 %)
 Extremely severe 6 (0.4 %)

Abbreviations: SD, standard deviation; DASS-21, Depression, Anxiety and Stress Scale; COVID-19, Coronavirus disease 2019; CNY, Chinese Yuan.